Cardiometabolic disease—spanning obesity, diabetes, and heart health—is redefining the future of employee wellbeing and workforce cost.
Join senior HR, benefits, and healthcare leaders for a strategic look at how employers are tackling this growing challenge through smarter benefit design, innovative therapies, and integrated care models.
Thursday, March 26, 2026 | 8:30 AM - 3:30 PM
Convene - 601 Lexington Avenue, New York City
Cardiometabolic disease—spanning obesity, diabetes, and heart health—is redefining the future of employee wellbeing and workforce cost.
Join senior HR, benefits, and healthcare leaders for a strategic look at how employers are tackling this growing challenge through smarter benefit design, innovative therapies, and integrated care models.
Explore how leading organizations are:
Managing the impact of GLP-1s and other high-cost therapies
Closing gaps in prevention, nutrition, and sleep health
Linking cardiometabolic programs to productivity and ROI
Advancing equity and sustainability in workforce health